Carregando… / Loading…
Clinical research platform
GIYUS mobilizes people, knowledge and technology to accelerate patient access to new treatments. A hub-and-spoke platform that turns scientific excellence into execution capacity.
Speed to advance. Rigor to trust.
GIYUS doesn't ask for trust — it demonstrates. These are operating commitments, not marketing copy.
Context
Law 14.874/2024 and Decree 12.651/2025 solved the number one reason Brazil used to lose clinical trials: regulatory unpredictability. The country is back on the map for global allocation decisions.
The immediate effect is a race for capacity. Far more studies will compete for a site base that is fragmented, heterogeneous and poorly managed. Brazilian sites have scientific excellence; what they lack is management capacity, speed and scale.
That is precisely the gap GIYUS fills.
Everything the platform does organizes around three verbs — and the first one gives the brand its name.
Connect the entire clinical research ecosystem into one coordinated network: investigators, sites, sponsors, technology, talent and knowledge.
Turn time into competitive advantage, with SLAs, targets and consequences. Every week saved in study start-up is earlier patient access to therapies.
All speed runs inside two absolute, non-negotiable rails: full regulatory compliance and ethics as the primary compass.
How it works
We don't compete on science with our scientific partners. We mobilize everything their science needs to move forward.
Everything comes from the same idea. Each audience has its own message, tone and — for participants — its own regulatory regime.
We mobilize sites that are ready to deliver.
Learn moreWe mobilize the structure so you can do science.
Learn moreWe mobilize talent — and make them owners of the outcome.
Learn moreWe mobilize what it takes for new treatments to reach you.
Learn moreManifesto
Science never advances alone.
It depends on people. On trust. On organization.
On speed. On ethics.
On those who turn knowledge into reality.
That is why we exist.
We mobilize investigators and sites.
We mobilize technology and talent.
We mobilize everything science needs to move forward.
Because every study started can mean a new treatment.
And every treatment can transform a life.
GIYUS. Mobilizing what accelerates new treatments.
Send a feasibility or talk to our commercial team. We respond within 48 to 72 hours.